CG Oncology Common stock Statistics Share Statistics CG Oncology Common stock has 76.23M
shares outstanding. The number of shares has increased by 13.64%
in one year.
Shares Outstanding 76.23M Shares Change (YoY) 13.64% Shares Change (QoQ) -0.79% Owned by Institutions (%) 91.59% Shares Floating 44.88M Failed to Deliver (FTD) Shares 1,028 FTD / Avg. Volume 0.11%
Short Selling Information The latest short interest is 10.78M, so 14.15% of the outstanding
shares have been sold short.
Short Interest 10.78M Short % of Shares Out 14.15% Short % of Float 14.98% Short Ratio (days to cover) 13.4
Valuation Ratios The PE ratio is -20.36 and the forward
PE ratio is -13.83.
CG Oncology Common stock's PEG ratio is
-0.22.
PE Ratio -20.36 Forward PE -13.83 PS Ratio 1573.67 Forward PS 22.1 PB Ratio 2.44 P/FCF Ratio -22.7 PEG Ratio -0.22
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for CG Oncology Common stock.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 35.3,
with a Debt / Equity ratio of 0.
Current Ratio 35.3 Quick Ratio 35.3 Debt / Equity 0 Debt / EBITDA n/a Debt / FCF n/a Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $10.08K Profits Per Employee $-779.11K Employee Count 113 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -27.33% in the
last 52 weeks. The beta is 0.88, so CG Oncology Common stock's
price volatility has been higher than the market average.
Beta 0.88 52-Week Price Change -27.33% 50-Day Moving Average 26.27 200-Day Moving Average 28 Relative Strength Index (RSI) 42.71 Average Volume (20 Days) 914,635
Income Statement In the last 12 months, CG Oncology Common stock had revenue of 1.14M
and earned -88.04M
in profits. Earnings per share was -1.41.
Revenue 1.14M Gross Profit 1.14M Operating Income -114.67M Net Income -88.04M EBITDA -114.63M EBIT -114.67M Earnings Per Share (EPS) -1.41
Full Income Statement Balance Sheet The company has 257.07M in cash and 238K in
debt, giving a net cash position of 256.83M.
Cash & Cash Equivalents 257.07M Total Debt 238K Net Cash 256.83M Retained Earnings -217.98M Total Assets 728.18M Working Capital 678.55M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -78.71M
and capital expenditures -234K, giving a free cash flow of -78.95M.
Operating Cash Flow -78.71M Capital Expenditures -234K Free Cash Flow -78.95M FCF Per Share -1.26
Full Cash Flow Statement Margins Gross margin is 100%, with operating and profit margins of -10067.25% and -7729.5%.
Gross Margin 100% Operating Margin -10067.25% Pretax Margin -7729.5% Profit Margin -7729.5% EBITDA Margin -10064.44% EBIT Margin -10067.25% FCF Margin -6931.26%
